Chemoinformaics analysis of (E)-5-hydroxy-2-isopropenyl-5-methyl-hex-3-enyl isobutyrate
Molecular Weight | 240.343 | nRot | 6 |
Heavy Atom Molecular Weight | 216.151 | nRig | 3 |
Exact Molecular Weight | 240.173 | nRing | 0 |
Solubility: LogS | -2.845 | nHRing | 0 |
Solubility: LogP | 2.706 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 41.789 |
nHD | 1 | BPOL | 26.681 |
QED | 0.573 |
Synth | 3.743 |
Natural Product Likeliness | 1.989 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.018 |
CACO-2 | -4.401 |
MDCK | 0.0000344 |
BBB | 0.968 |
PPB | 0.704727 |
VDSS | 1.147 |
FU | 0.381326 |
CYP1A2-inh | 0.06 |
CYP1A2-sub | 0.16 |
CYP2c19-inh | 0.093 |
CYP2c19-sub | 0.856 |
CYP2c9-inh | 0.034 |
CYP2c9-sub | 0.489 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.64 |
CYP3a4-inh | 0.084 |
CYP3a4-sub | 0.341 |
CL | 6.772 |
T12 | 0.667 |
hERG | 0.009 |
Ames | 0.008 |
ROA | 0.052 |
SkinSen | 0.042 |
Carcinogencity | 0.419 |
EI | 0.187 |
Respiratory | 0.385 |
NR-Aromatase | 0.004 |
Antiviral | Yes |
Prediction | 0.786973 |